Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study.

Multigene, RNA-based low AR expression is associated with aggressive disease characteristics as well as DNA repair defects and immune phenotypes, suggesting plausible precision therapies for AR-low, ER-negative patients.